- Types of Sarcoma, a Deeper Look at a Few of the Subtypes
March 11, 2023
- Sarcoma Science Highlights
March 10, 2023
- Moffitt's Gastrointestinal Team Completes its 100th Robotic Whipple Surgery
March 07, 2023
- Tumor Infiltrating Lymphocytes (TILs) Clinical Trial Provides Hope for Recurrent or Metastatic Cervical Carcinoma Patients
March 03, 2023
- Q&A: Dr. Gustainyte Explains Uterine Fibroid Embolization Procedure in Patients with Uterine Fibroids
March 02, 2023
- Your Vote Counts! U.S. News Physician Survey is Underway
February 24, 2023
- New Study on Management and Treatment of Vaginal Mucosal Melanoma
February 23, 2023
- Highlights of Moffitt Science Presented at Tandem Meetings of ASTCT and CIMBTR
February 15, 2023
- New Clinical Trial Aims to Genomically Personalize Radiation Therapy for Breast Cancer
February 14, 2023
- Q&A: Dr. Al-Roubaie Discusses Hemorrhoid Embolization Procedure in Treating Internal Hemorrhoids
January 31, 2023
- 6 Common Bone Marrow Transplant Misconceptions for Leukemia Patients
January 27, 2023
- Study Shows Seaweed Sugar (L-fucose) May Trigger Immune Responses That Combat Melanoma
January 26, 2023
- Transperineal Biopsy Shows Promising Results for Prostate Cancer Diagnostics
January 20, 2023
- Health Insurance Literacy Study in Head and Neck Cancer Patients and Caregivers
January 17, 2023
- Moffitt's Endocrine Oncology Program Multidisciplinary Approach to Cancer Care
January 17, 2023
- Sentinel Lymph Node Mapping for Uterine Cancer
January 15, 2023
- Clinscience and OncoBay Clinical Partner to Expand Immuno-Oncology Research Globally
January 10, 2023
- Moffitt Partners with IBA for Proton Therapy
January 09, 2023
- Ovarian Transposition an Option for Fertility Preservation for Some Cervical Cancer Patients
January 06, 2023
- Phase 1 Study Evaluating the Combination of 3 Immunotherapies in Metastatic HER2-Positive Breast Cancer Patients
December 13, 2022
- Knowing When Minimally Invasive Cancer Surgery is the Best Treatment Option Can Saves Lives
December 08, 2022
- Predicting IPMN Pathology Using Noninvasive Radiogenomics
December 08, 2022
- Phase 1 Trial: Evaluating Claudin18.2-Specific CAR T Cells in Gastrointestinal Cancers
December 06, 2022
- Q&A: Dr. Mok Shares His Role as an Advanced Endoscopist
December 06, 2022
- Identification of Targetable Gene Fusions Present in KRASWT Pancreatic Adenocarcinoma and the Response to Targeted Therapy
December 02, 2022
- 5-ALA is Transforming the Treatment of Glioblastoma
December 01, 2022
- A New Approach to Cancer Diagnostics
December 01, 2022
- Innovative Margin Assessment Technology Presents Positive Outcomes in Breast Cancer Surgery
November 28, 2022
- Moffitt Connecting National Experts for Myeloma Immunotherapy Breakthroughs
November 21, 2022
- Using CUE-101 in Combination with Pembrolizumab in Treating Recurrent/Metastatic HPV16+ Head and Neck Cancer
November 17, 2022
- MRgSBRT Demonstrates Advantages in Treatment for Adrenal Gland Metastases
November 10, 2022
- Dr. Ahmed Tests the Response of Systemic Therapies or Radiation Across Different Metastatic Disease Sites
November 10, 2022
- Outcomes in Patients with Metastatic Pancreatic Adenocarcinoma When Administering MRI-Guided Adaptive Radiation Therapy
November 09, 2022
- SpaceOAR Hydrogel Offers Promising Outcomes for Prostate Cancer Patients Receiving Radiation
November 08, 2022
- 8 Reasons to Consider Clinical Trials First
November 01, 2022
- The Use of Radiomics in Breast Imaging May Result in Improved Patient Outcomes
October 28, 2022
- Medical Mission Provides Life-Saving Surgeries in Guatemala
October 24, 2022
- Better Outcomes for Lung Cancer Using Robotic Bronchoscope
October 19, 2022
- Lung Cancer in Nonsmokers May be Linked to Air Pollution
October 19, 2022
- Dr. Chen Presents Research Findings from Cutaneous T-cell Lymphoma Study
October 03, 2022
- Cysview Blue Light Cystoscopy Technology for Bladder Cancer Available at Moffitt Cancer Center
September 23, 2022
- Top Treatment Developments in Cancer Care
September 21, 2022
- Top 5 Misconceptions About Referring Patients to Moffitt
September 20, 2022
- Q&A: Dr. McMullen Receives National Recognition as AWS 40 Under 40 Female Surgeons
September 19, 2022
- Minimally Invasive Surgery Approach for Paraspinal Lumbar Schwannomas
September 08, 2022
- Distant Margins Following Pelvic Exenteration Improve the Survival Rate for Women with Gynecologic Cancer
September 06, 2022
- What You Need to Know About Minimally Invasive Surgery for Gynecologic Cancers
September 06, 2022
- Q&A with Dr. Michael Vogelbaum on Stereotactic Radiosurgery for Brain Tumors
September 02, 2022
- Gynecologic Cancer Genetics and Molecular Medicine Tumor Board at Moffitt Cancer Center
August 30, 2022
- Q&A: Dr. Alice Yu Discusses Management of Localized Prostate Cancer Using Irreversible Electroporation Ablation
August 23, 2022
- Fluorescent Imaging Technology Now Available At Moffitt For Ovarian Cancer Surgery
August 18, 2022
- Q&A: Dr. Yamoah Shares His Vision for Moffitt To Become Global Epicenter for Precision Radiotherapy
August 18, 2022
- Some Cancer Symptoms More Likely to Present in Emergency Rooms
August 17, 2022
- How the IPOP Service Is Shaping the Standard of Care in Infusion Centers
August 16, 2022
- Understanding Chronic Myelogenous Leukemia (CML)
August 03, 2022
- Refining Multiple Myeloma Treatments: the EMMA Created at Moffitt
August 03, 2022
- Lung Nodules and Lung Cancer Early Detection
July 26, 2022
- Specialized Clinic for Bone Lesions and Bone Metastasis
July 26, 2022
- Immune Checkpoint Inhibitor Targeting LAG3 May Lead to Therapeutic Approaches in Advanced Melanoma
July 14, 2022
- Research Presented on Baseline Metastatic Patterns and Clinical Outcomes Among BRAF-Positive Metastatic Melanoma Patients
July 12, 2022
- 11-Gene Expression Signature May Predict Sentinel Lymph Node Metastatic Status in Melanoma Patients
July 12, 2022
- Advancements in Treatment for Breast and Gynecologic Cancers
June 29, 2022
- Moffitt Researcher Receives Grant to Study Immunogenic Activity of Oncolytic Virus and Immune Checkpoint Blockade
June 21, 2022
- Malignant Hematology ASCO Highlights
June 16, 2022
- Cellular Immunotherapy Highlights from ASCO
June 16, 2022
- Gastrointestinal Oncology Presented Research Studies at ASCO 2022
June 16, 2022
- Bladder Cancer Treatment Advancement Roundup
June 14, 2022
- Gut Microbiome/Metabolome Predicts Response to Immune Checkpoint Blockers in Patients with Recurrent Metastatic Head and Neck Squamous Cell Cancer
June 13, 2022
- Phase 1 Dose-Escalation/Expansion Study of CUE-101 Given in Patients with Recurrent/Metastatic HPV16+ Head and Neck Cancer
June 10, 2022
- MRIdian® MRI-Guided Radiation Therapy Shows Positive Results in Treatment of Ultracentral/Central Lung Tumors
May 23, 2022
- Age is Just a Number When it Comes to Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
May 12, 2022
- Improving Brain Metastases Outcomes Through Stereotactic Radiosurgery and Immunotherapies
May 09, 2022
- Age-Related Disparity in Treatment Outcome Among Patients with Metastatic Colorectal Cancer
May 04, 2022
- New Non-Small Cell Lung Cancer Biomarkers Found
April 28, 2022
- Neoadjuvant Therapy Proves Effective in Muscle Invasive Bladder Cancer
April 25, 2022
- Minimally Invasive Surgery Advancements for Spinal Tumor Surgery
April 07, 2022
- Methylthioadenosine Phosphorylase (MTAP) Pathway for Genitourinary Cancers
April 05, 2022
- Radiation Oncologist Relates to Cancer Patients 'More Than They Know'
April 04, 2022
- FDA Approves Targeted Radioligand Therapy for Treatment of Advanced Prostate Cancer
March 30, 2022
- The Latest Advances in Breast Cancer Therapeutics: CDK-Inhibitors to Cellular Immunotherapy
March 30, 2022
- Engaging the Community Against Cancer
March 18, 2022
- Working to Overcome Health Disparities
March 18, 2022
- Sarcoma is Not a Single Disease, There are Actually More Than 70 Subtypes
March 18, 2022
- Second-Line Therapy for Large B-Cell Lymphoma
March 15, 2022
- Promises of Cell Therapy Bring Opportunities for Collaboration and Clinical Excellence
March 09, 2022
- The Latest Research in Head and Neck-Endocrine Cancer Treatment
March 08, 2022
- Advanced Renal Cell Carcinoma Patients Sought for Autologous Dendritic Cell Immunotherapy Clinical Trial
March 08, 2022
- Moffitt Researchers Lead Study Identified ctDNA for the Treatment of High-Risk Urothelial Carcinoma
March 04, 2022
- Q&A: Dr. Agosto Shares Her Role as an Endocrine Oncologist
February 28, 2022
- Dr. Vogelbaum Leads the Development of the National Guidelines for Metastatic Brain Tumor Treatment
February 23, 2022
- Cancer Immunotherapy Breakthrough: Dendritic Cell Vaccines
January 24, 2022
- U.S. House Passes HPV Cancer Legislation
January 24, 2022
- Hyperthermic Intraperitoneal Chemotherapy: Benefits of the Procedure for Peritoneal Disease Explained
January 21, 2022
- mRNA Vaccine Technology Being Studied for Head & Neck Cancer
January 20, 2022
- Novel Immunotherapy Trial using Chimeric Antigen Receptor Therapy (CAR T) for Relapsed Epithelial Ovarian Cancer
January 10, 2022
- Understanding the Effects of the COVID Vaccine on Cancer Patients
December 16, 2021
- A new type of CAR T called UltraCAR-T™ potentially a therapy for myeloid malignancies
December 16, 2021
- Predicting Outcomes to Immunotherapy for NSCLC
October 08, 2021
- Third Annual Retreat Sheds Light on Cancer Health Disparities
September 16, 2021
- Therapeutic Treatment Advancement for Metastatic HER2-positive Breast Cancer
September 10, 2021
- Moffitt and Ringling College of Art & Design Partner Utilizing Virtual Reality to Enhance the Patient Experience
September 03, 2021
- New Tools and Techniques for Improved Surgical Outcomes for Patients with Brain Tumors
September 01, 2021
- The Utility of Trastuzumab Monotherapy in HER2+ Breast Cancer
August 24, 2021
- Minimally Invasive Robotic Surgery - The Latest Advancement in Surgical Cancer Care
August 20, 2021
- Endometrial Cancer: Routes of Surgery
August 04, 2021
- Virtual Cancer Care Enhances Our Patient Experience
July 13, 2021
- Exploring the Many Known and Suspected Health Benefits of Canine Ownership
July 07, 2021
- New Study Finds "Off the Shelf CAR-T" Promising for Certain Lymphoma Patients
July 01, 2021
- Comprehensive Molecular Profiling of Undifferentiated Embryonal Sarcoma of the Liver
June 10, 2021
- Percutaneous Hepatic Perfusion in Patients with Hepatic-dominant Ocular Melanoma
June 08, 2021
- GRECO-2 Trial Could Show Promising Results for Pancreatic Cancer
June 08, 2021
- TVEC for the Treatment of Early Stage Triple Negative Breast Cancer
June 07, 2021
- Reshaping the Frontline Treatment Landscape of ES-SCLC
June 03, 2021
- Improving Representation of Racial and Ethnic Minorities in Lung Cancer Screening Programs
May 25, 2021
- Macrophage Tumor Cell Metabolic Interactions Induce Therapeutic Resistance in Prostate Cancer
May 04, 2021
- Circulating tumor DNA (ctDNA) MRD Detection from Plasma and Urine and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer
April 10, 2021
- In Silico Trial Estimates Personalized Radiation Therapy Dose in Head and Neck Cancer
April 10, 2021
- Pushing for a Cure: New Treatments for Head and Neck-Endocrine Cancer
April 08, 2021
- Moffitt Women Faculty: By the Numbers
April 05, 2021
- Head and Neck Cancer Vaccine Trial on the Horizon
March 31, 2021
- Novel Immunotherapy and Chemotherapy in Patients with Ovarian Cancer
March 30, 2021
- Meet Our Endoscopic Endonasal and Skull Base Tumor Surgeon
March 23, 2021
- Our Commitment to Your Patients
March 01, 2021
- Novel Treatment for Brain Cancer Using Immune Checkpoint Inhibitors
February 23, 2021
- Moffitt Study Seeks to Inform Improved Treatment Strategies for Clear Cell Renal Cell Carcinoma
February 11, 2021
- Ethnicity’s Role in Checkpoint Blockade Therapies
February 04, 2021
- Nationally Recognized Cancer Care Now Available in Wesley Chapel
February 01, 2021
- Nationally Recognized Cancer Care Now Available in Wesley Chapel (1)
February 01, 2021
- Oral Sex Habits and HPV-Related Oropharyngeal Cancer Risk
January 29, 2021
- Advancement in Gynecologic Cancer Treatment Using Immune Checkpoint Inhibitors
November 03, 2020
- The Future of Immune Checkpoint Inhibitors for Genitourinary Cancers
November 03, 2020
- CAR T Clinical Trials for Multiple Myeloma Bring Promising New Treatments
October 13, 2020
- The Future of CAR T for Gynecologic Cancers
October 08, 2020
- Targeted Therapy in Thyroid Cancer
September 23, 2020
- Radioactive Iodine Treatment in Patients with Thyroid Cancer
September 23, 2020
- Nonsurgical Treatment of Thyroid Nodules
September 18, 2020
- Endocrine Effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)
September 18, 2020
- Expanding TILs Beyond Melanoma – Sarcoma Study Now Open
August 21, 2020
- Prostatic Artery Embolization: A Non-surgical Treatment for Chronic Prostatitis/Chronic Pelvic Pain from Radiation-Induced Prostatitis
July 27, 2020
- PARP Inhibitors Improve Survival Rate in Some Relapsed Ovarian Cancer Patients
July 20, 2020
- TIL Immunotherapy Offers Promising Results in Metastatic Non-Small Cell Lung Cancer
July 10, 2020
- Preclinical Research Uses Oncolytic Adenovirus That Selectively Kills Cancer Cells While Revving Up The Immune System
July 10, 2020
- Artificial Intelligence Achieves Human-Level Performance on Several Natural Language Processing Pathology Benchmarks
July 10, 2020
- Geriatric Oncology Offers Prolonged Life Spans for Older Cancer Patients
July 06, 2020
- August is National Immunization Awareness Month
July 02, 2020
- Exploring Application of TILs for Head and Neck Cancers
June 23, 2020
- Researchers Use Intratumor Heterogeneity to Understand Eco-evolutionary Dynamics of Tumors
June 22, 2020
- Optimizing Cancer Care Using Digital Technologies Requires Coordinated Multi-Stakeholder Effort
June 04, 2020
- Stereotactic Body Radiation May be a Treatment Option for Unresectable Recurrent Head and Neck Cancers
June 03, 2020
- The World’s First T-cell Therapy for a Solid Tumor Cancer is Poised for Approval via Moffitt Partnership
June 03, 2020
- Veliparib Monotherapy Study Suggests Benefits for Advanced HER2 Negative Breast Cancer Patients
June 01, 2020
- Novel Role of Specific Histone Deacetylase in Non-Small Cell Lung Cancer Discovered
May 14, 2020
- Collaboration on New Developments for Robotic Lung Surgery Computer Interface
May 14, 2020
- Moffitt’s Molecular Biology Lab Creates Own COVID-19 Diagnostic Test
April 30, 2020
- Virtual Oncology Visits Are Up 5,000% at Moffitt— Are They Here to Stay After COVID-19?
April 28, 2020
- Moffitt’s HPV Research Impacts Practice and Policy Worldwide
April 27, 2020
- Grand Opening of New Moffitt Clinic Dedicated to Immune Cell Therapy
February 11, 2020
- Novel Drug Delivery Tool Enhances Treatment of Recurrent Glioblastoma
February 03, 2020
- Innovative 3D Visualization Technology Enhances Brain Cancer Treatment
December 16, 2019
- Moffitt Researchers Utilize the Genomic-Adjusted Radiation Dose to Personalize Radiotherapy in Cancer Care
December 02, 2019
- The Moffitt STAR™ Solid Tumor Assay as a Tool to Guide Clinical Decisions
October 03, 2019
- Advances in Breast Cancer Immunotherapy Research for Brain-Metastatic Breast Cancer
October 01, 2019
- FDA Approved First CAR-T Gene Therapy
August 30, 2017
